A senate committee has heard from generic drug makers that the government has a key role in bringing the production of critical drugs back to the US. The issue of generic drug pricing and safety is being discussed on Capitol Hill, with some citing patent issues and the potential for foreign manufacturers to stop production as concerns. The US may not have a backup plan if foreign generic drug makers were to cease production, and senate democrats are exploring ways to reduce patient costs.